ArticleDiabetology & metabolic syndrome2024

Impact of SGLT-2 inhibitors on modifiable cardiovascular risk factors in Romanian patients with type 2 diabetes mellitus.

Adriana Gherbon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.